ArticleInvestigative ophthalmology & visual science2026
Altered Carnitine Homeostasis Modulates Hyperosmolarity-Induced Mitochondrial Dysfunction and Lipotoxicity in Human Corneal Epithelial Cells.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Purpose: Tear hyperosmolarity, a hallmark of dry eye disease (DED), contributes to corneal epithelial injury, inflammation, and mitochondrial dysfunction. This study examined the effects of hyperosmolar stress on mitochondrial carnitine metabolism in human telomerase-immortalized corneal epithelial (hTCEpi) cells and evaluated the osmoprotective potential of L-carnitine supplementation. Methods: The hTCEpi cells were exposed to 90 mM NaCl to induce 490 mOsM hyperosmolar conditions, with or without 200 mM L-carnitine supplementation. Free fatty acid (FFA) uptake, triglyceride (TG) accumulation, lipid peroxidation, and mitochondrial reactive oxygen species (mtROS) were quantified using fluorometric and colorimetric assays. The expression and activity of carnitine palmitoyltransferases (CPT1 and CPT2), carnitine acetyltransferase (CrAT), and peroxisome proliferator-activated receptor alpha (PPARα) were assessed, and intracellular ATP levels were measured as indicators of mitochondrial function. Results: Hyperosmolar stress markedly increased lipid uptake, TG accumulation, malondialdehyde (MDA) levels and mtROS generation. CPT1, CPT2, and CrAT expression and activity and ATP levels were decreased, whereas inducible nitric oxide synthase (iNOS) expression was upregulated. L-carnitine supplementation significantly reduced lipid accumulation and peroxidation, decreased mtROS production, and partially restored ATP generation. It also enhanced total CPT and CrAT enzyme activities, indicating recovery of carnitine shuttle function. Conclusions: These findings demonstrate that hyperosmolarity disrupts carnitine homeostasis, and leads to lipotoxicity, oxidative stress, and reduced ATP production. In contrast, L-carnitine supplementation restores carnitine-dependent mitochondrial pathways and may represent a potential therapeutic strategy to protect the ocular surface from hyperosmolar injury in DED.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.